彰化基督教醫院 全方位乳房腫瘤中心

全方位乳房腫瘤中心


 醫師介紹

陳守棟
陳達人
蘇進成
胡華?
王全正
曾信順
賴鴻文
林(吉吉)
廖淑芬
林敬翰
蘇進成 主治醫師
學經歷
最高學歷:
中國醫藥大學 醫學博士(2003/09~2006/06)

醫師證照:
台灣外科醫學會 外科專科醫師
台灣消化外科醫學會 消化外科專科醫師
台灣乳房醫學會 乳房外科專科醫師
台灣臨床腫瘤醫學會 臨床腫瘤專科醫師
中華民國醫用超音波學會 超音波專科醫師
世界中醫藥學會第一屆腫瘤專業委員會理事
美國癌症研究協會 (American Association for Cancer Research) 會員
美國臨床腫瘤醫學會 (American Society of Clinical Oncology) 會員

經歷:
中國醫藥大學附設醫院 一般外科主治醫師 (1998/07~2005/12)
花蓮慈濟醫學中心 一般外科主任 (2007 /07 ~2008/11)
花蓮慈濟醫學中心 乳房中心主任 ( 2008/ 12~2010/ 06)
慈濟大學醫學系 專任助理教授
彰化基督教醫院 體系乳房中心 協同主任 (2011 / 01 ~2015/06)
鹿港基督教醫院 乳房中心主任 (2011 / 01 ~2015/06)
明道大學 兼任副教授


現任:
彰化基督教醫院 外科部 部協同主任 (2011 / 01 ~迄今)
彰化基督教醫院 中西醫結合腫瘤研究中心 主任 (2012 / 01 ~迄今)
彰化基督教醫院 全方位乳房腫瘤中心 主治醫師 (2011/01迄今
中國醫藥大學 兼任助理教授


最近五年 國際期刊發表
1. Chuang WL ,*Su CC , Lin PY , Lin CC , Chen YL. Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways. Mol Med Rep. 2015 Aug;12(2):1677-84. doi: 10.3892/mmr.2015.3573. Epub 2015 Mar 31. (SCI)

2. *Su CC, Chen CJ , Kuo SJ , Chen DR . Myoid hamartoma of the breast with focal chondromyoxid Metaplasia and pseudoangiomatous stromal hyperplasia: A case report. Oncol Lett. 2015 Apr; 9(4):1787-1789. Epub 2015 Jan 23. (SCI)

3. *Su CC. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of mammalian target of rapamycin but increases microtubule associated protein II light chain 3 expression to inhibit human BxPC 3 pancreatic carcinoma cells. Mol Med Rep. 2015 Apr; 11(4):3160-6. doi: 10.3892/mmr.2014.3090. Epub 2014 Dec 15. (SCI)

4. *Su CC. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res. 2014 Dec; 34(12):7097-110. (SCI)

5. *Su CC. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing Bip, TCTP, Mcl-1 and Bcl-xL and increasing Bax and CHOP protein expression. International Journal of Molecular Medicine. 2014 Sep 29. Doi:10.3892/ijmm.2014.1949. Epub 2014 Sep 29. (SCI)

6. Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, * Su CC, Chen DR. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013 Oct; 22(5):968-73. doi: 10.1016/j.breast.2013.05.010. Epub 2013 Jun 17.

7. Chien SY, Kuo SJ, Chen DR, *Su CC. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl 1 and TCTP and increases that of TNF-α and Bax in BxPC 3 pancreatic carcinoma cells. International Journal of Molecular Medicine. 2013 Jul;32(1):85-92. doi: 10.3892/ijmm.2013.1369. Epub 2013 May 8. (SCI)

8. Chen YL, Yan MY, Chien SY, Kuo SJ, Chen DR, Cheng CY, *Su CC. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Mol Med Rep. 2013 May;7(5): 1487-93. doi: 10.3892/mmr.2013.1381. Epub 2013 Mar 20. (SCI)

9. Huang CY, Chiu TL, Kuo SJ, Chien SY, Chen DR, *Su CC. Tanshinone IIA inhibits the growth of pancreatic cancer BxPC 3 cells by decreasing protein expression of TCTP, MCL 1 and Bcl xL. Mol Med Rep. 2013 Mar;7(3):1045-9. doi: 10.3892/mmr.2013.1290. Epub 2013 Jan 25. (SCI)

10. Chiu TL, Wang MJ, *Su CC. The treatment of glioblastoma multiforme through activation of microglia and TRAIL induced by rAAV2-mediated IL-12 in a syngeneic rat model. J Biomed Sci. 2012 Apr 22;19:45. doi: 10.1186/1423-0127-19-45. (SCI)

11. *Su CC. Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med. 2012 Mar;3(3):555-559. Epub 2011 Dec 28.

12. Yan MY, Chien SY, Kuo SJ, Chen DR, *Su CC. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression. International Journal of Molecular Medicine. 2012 May;29(5):855-63. doi: 10.3892/ijmm.2012.908. Epub 2012 Feb 7. (SCI)

13.*Su CC, Chien SY, Kuo SJ, Chen YL, Cheng CY, Chen DR. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65. Mol Med Rep. 2012 Apr;5(4):1019-22. doi: 10.3892/mmr.2012.756. Epub 2012 Jan 13. (SCI)

14. Chien SY, Kuo SJ, Chen YL, Chen DR, Cheng CY, *Su CC. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Mol Med Rep. 2012 Jan;5(1):282-6. doi: 10.3892/mmr.2011.631. Epub 2011 Oct 14. (SCI)

15. Chan SE, Lai HW, *Su CC, Kuo SJ, Chien SY, Lin HY, Chen DR. Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study. Evid Based Complement Alternat Med. 2011;2011:841564. doi: 10.1155/2011/841564. Epub 2011 May 24.

16. Cheng CY, *Su CC. Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential. Mol Med Rep. 2010 Jul-Aug;3(4):645-50. doi: 10.3892/mmr_00000310. (SCI)

17. Cheng CY, Lin YH, *Su CC. Anti-tumor activity of Sann-Joong-Kuey-Jian-Tang alone and in combination with 5-fluorouracil in a human colon cancer colo 205 cell xenograft model. Mol Med Rep. 2010 Mar-Apr;3(2):227-31. doi: 10.3892/mmr_00000244. (SCI)

18. Cheng CY, Lin YH, *Su CC. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. International Journal of Molecular Medicine. 2010 Nov;26(5):673-8. (SCI)
專長
乳房超音波檢查
乳房良性腫瘤 整形式切除手術
乳房腫瘤 超音波導引 切片及微創手術
乳房攝影細針定位後 鈣化切片手術
乳癌整形式腫瘤切除手術及乳癌化療
中西醫結合癌症治療研究

回上頁


 彰化基督教醫院 版權所有 500 彰化市南校街135號 全方位乳房腫瘤中心 瀏覽人次瀏覽人次 44394        © 2010 Changhua Christian Hospital All Rights Reserved.